Mr. Floyd brings over 30 years of global medical device experience focused on market development products and technologies. He is highly experienced commercializing disposables, implants, capital equipment and monitoring systems. Mr. Floyd was most recently Executive Vice President, Worldwide Sales and Marketing at Aspect Medical Systems, Inc. He managed Aspect Medical Systems, Inc. from $19M in revenue and a $20M operating loss to over $110+M revenue and $16+M operating profit over a 7 year period prior to its sale to Covidien in 2009. Prior to Aspect, Mr. Floyd was VP Marketing at Boston Scientific for 5 years. There he developed and executed the Urology division’s 5 year Strategic plan focused on growth and diversification which led to two acquisitions and numerous licensing and distribution agreements. He has also held numerous senior sales and marketing positions with Johnson & Johnson (Codman & Shurtleff) and Proctor and Gamble. He is a graduate from the University Of Vermont.

Mr. Schaefer has over sixteen years of executive experience. Mr. Schaefer joined CSA Medical, Inc. full-time in 2006 as CFO and most recently was appointed President with a focus on expanding the growth of the GI business line. Previously, Mr. Schaefer was CEO of Schaefer & Associates, a Maryland-based consulting firm specializing in corporate advisory services for high growth companies where he began serving as a Board Member for CSA Medical. A Certified Public Accountant, he earned his degree in accounting and finance from Drexel University in Philadelphia.

Dr. Burr joined CSA Medical, Inc. in 2008 as the Company’s Chief Technology Officer. Dr. Burr has been developing and bringing successful new technologies to the market place for 25 years. Prior to joining CSA Medical, he served as Platform Manager at Becton Dickinson Molecular Diagnostics leading cross-functional teams of R&D, operations, medical, regulatory, service, quality, marketing and finance in the design, implementation, validation and introduction of automated instruments. Previously, Dr. Burr served as CTO at MacroSonix Corp. and Director of R&D at Tektronix Inc. Dr. Burr earned his Ph.D. and MS in Mechanical Engineering from the University of Illinois, MS from the University of Southern California, and his BS from the University of Washington. A distinguished innovator, Dr. Burr currently holds 20 patents.

Mr. Hughen has over twenty years of professional experience in sales and marketing leadership, product management and strategic planning. He has successfully grown businesses in diverse environments including start up, mid-cap and fortune 100 companies. After spending five years with Johnson & Johnson and twelve years with Abbott Diagnostics, Mr. Hughen directed the marketing strategy and operations for the $120M molecular diagnostics business of Becton, Dickinson and Co. Mr. Hughen is a graduate of The Pennsylvania State University with an MBA in Marketing and BS in Environmental Science.

Ms. Strusky has over twenty years of professional experience in conceptual and clinical selling, sales management, strategic planning, new market development and sales training. After spending eight years with Baxter Healthcare and eight years with STERIS Corporation, Ms. Strusky propelled start up Aspect Medical Systems from $15 million to $70 million in domestic brain monitoring sales capturing the market leadership position. Ms. Strusky is a graduate of Purdue University with a Bachelor of Science in Management.